At Diaceutics, we have known for a long time that Laboratories’ role is crucial to the timely application of innovations in Precision Medicine. That is why Diaceutics launched DXRX-The world’s first Diagnostic Network® for Precision Medicine around laboratories’ role1 to deliver on the right drug, to the right patient, at the right time.
This decision is the result of Diaceutics’ engagement with laboratories at the local, regional and global level, from the moment the first targeted therapy was commercialized, to Diaceutics being involved on every Precision Medicine ever brought to market2.
This decades-long relationship has resulted in the growth of a broad laboratory network, which has generated extensive data to provide the necessary insights to support the type of strategy needed, when introducing an innovative therapeutic into market. All to contribute to improve on patient outcomes.
For laboratories, this type of engagement with Diaceutics has provided them with the opportunity to interact with their data in a new and dynamic way. Through benchmarking reports at the end of each project, labs have the opportunity to see in a safe manner, how they perform against other labs. Additionally, in the reports, Diaceutics captures guidelines at country, regional and global level, helping shape understanding for each lab as to where they are in a patient’s testing journey and whether action is required to improve on their position to deliver on vital, innovative care.
The power of that network effect through data3, creates a bigger picture which allows for labs to maneuver, based on facts, as to how their testing practices relate, to the actual testing needs of patients and physicians relying on them.
With this level of awareness, labs are prepared to act swiftly to, for example, ensure that they are included earlier in the patient testing journey, or even anticipate to upcoming testing needs because of new diagnostic reliant therapeutics coming into guidelines.
Register here to learn more about collaborations like the benchmark reports and joining this vibrant Precision Medicine network.
We are committed to the accelerated and quality-driven delivery of diagnostic reliant innovation to get every patient the treatment they deserve.